# Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach

> **NCT00002682** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 5 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** Amoxicillin
- **DRUG:** Bismuth Subsalicylate
- **DRUG:** Clarithromycin
- **DRUG:** Metronidazole Hydrochloride
- **DRUG:** Omeprazole
- **DRUG:** Tetracycline Hydrochloride

## Key facts

- **NCT ID:** NCT00002682
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-08-10
- **Primary completion:** 2001-10-08
- **Final completion:** 2001-10-08
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2018-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002682, "Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00002682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*